BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1984082)

  • 1. End stage renal disease serum contains a specific renal cell growth factor.
    Klotz LH; Kulkarni C; Mills G
    J Urol; 1991 Jan; 145(1):156-60. PubMed ID: 1984082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
    Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
    Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum renotropic factor stimulates prostaglandin synthesis in primary cultures of rabbit kidney cells.
    Logan JL; Benson B
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):183-6. PubMed ID: 2281121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum from patients with chronic renal insufficiency alters growth characteristics and ANP mRNA expression of adult rat cardiac myocytes.
    Yu JZ; Bondy GP; Allard MF; Thompson CR; Levin A; McManus BM
    J Mol Cell Cardiol; 1996 Dec; 28(12):2429-41. PubMed ID: 9004160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion of autocrine growth-promoting activity by renal-carcinoma cells treated with 5-fluorouracil.
    Nishimura N; Kanda S; Yogi Y; Kawamura M; Nakamura M; Hyakutake H; Kanetake H; Saito Y
    Int J Cancer; 1992 Aug; 52(1):105-9. PubMed ID: 1500215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA; Klos DJ; Grant GA
    Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver.
    Pickart L; Thaler MM
    Nat New Biol; 1973 May; 243(124):85-7. PubMed ID: 4349963
    [No Abstract]   [Full Text] [Related]  

  • 8. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells.
    Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA
    Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncated fibronectin. An autologous growth-promoting substance secreted by renal carcinoma cells.
    Kochevar GJ; Stanek JA; Rucker EB
    Cancer; 1992 May; 69(9):2311-5. PubMed ID: 1348659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High risk of development of renal cell tumor in end-stage kidney disease: the role of microenvironment.
    Nagy A; Walter E; Zubakov D; Kovacs G
    Tumour Biol; 2016 Jul; 37(7):9511-9. PubMed ID: 26790439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proliferative responsiveness of mesangial cells to postnephrectomy serum declines progressively with time elapsing after contralateral nephrectomy.
    Weissgarten J; Modai D; Cohn M; Berman S; Averbukh Z
    Nephron; 1998; 78(2):212-4. PubMed ID: 9496740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth.
    Gospodarowicz D
    Nature; 1974 May; 249(453):123-7. PubMed ID: 4364816
    [No Abstract]   [Full Text] [Related]  

  • 13. Blockage of autonomous growth of ACHN cells by anti-renal cell carcinoma monoclonal antibody 5F4.
    Kochevar J
    Cancer Res; 1990 May; 50(10):2968-72. PubMed ID: 2334900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of platelet growth factor(s) on growth of human tumor colonies.
    Cowan DH; Graham J
    Prog Clin Biol Res; 1982; 89():249-68. PubMed ID: 7111300
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of growth factors in renal cell carcinoma.
    Nakamoto T; Usui A; Oshima K; Ikemoto H; Mitani S; Usui T
    Biochem Biophys Res Commun; 1988 Jun; 153(2):818-24. PubMed ID: 3260099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
    Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
    J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of a type beta transforming growth factor from bovine kidney.
    Roberts AB; Anzano MA; Meyers CA; Wideman J; Blacher R; Pan YC; Stein S; Lehrman SR; Smith JM; Lamb LC
    Biochemistry; 1983 Dec; 22(25):5692-8. PubMed ID: 6607069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G Protein Coupled Receptor 87 (GPR87) in End Stage Kidney and Associated Tumors.
    Beothe T; Kovacs G; Peterfi L
    Anticancer Res; 2024 Feb; 44(2):555-559. PubMed ID: 38307566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
    Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
    J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced levels of retinyl esters and vitamin A in human renal cancers.
    Guo X; Nanus DM; Ruiz A; Rando RR; Bok D; Gudas LJ
    Cancer Res; 2001 Mar; 61(6):2774-81. PubMed ID: 11289161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.